Cargando…
T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human
Genetically engineered T cells expressing a T-cell receptor (TCR) are powerful tools for cancer treatment and have shown significant clinical effects in sarcoma patients. However, mismatch of the introduced TCR α/β chains with endogenous TCR may impair the expression of transduced TCR, resulting in...
Autores principales: | Sun, Qian, Zhang, Xiying, Wang, Limei, Gao, Xujie, Xiong, Yanjuan, Liu, Liang, Wei, Feng, Yang, Lili, Ren, Xiubao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572850/ https://www.ncbi.nlm.nih.gov/pubmed/31209257 http://dx.doi.org/10.1038/s41419-019-1717-8 |
Ejemplares similares
-
Endogenous TCR Recombination in TCR Tg Single RAG-Deficient Mice Uncovered by Robust In Vivo T Cell Activation and Selection
por: Montaudouin, Caroline, et al.
Publicado: (2010) -
Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs
por: Hui, Zhenzhen, et al.
Publicado: (2021) -
Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor
por: Zhang, Ge, et al.
Publicado: (2014) -
Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
por: Ikeda, Hiroaki, et al.
Publicado: (2014) -
CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma
por: Su, Juan, et al.
Publicado: (2016)